IgG4-related epididymo-orchitis associated with bladder cancer: Possible involvement of BAFF/BAFF-R interaction in IgG4-related urogenital disease

Modern Rheumatology

Volumn 24, Issue 1, 2014, Pages 188-194

  Migita, Kiyoshi ^a   Miyashita, Taiichiro ^a   Mizuno, Aya ^a   Jiuchi, Yuka ^a   Ito, Masahiro ^a   Matsuo, Manabu ^b   Izumi, Yasumori ^a   Takeoka, Atsushi ^a   Nishino, Ayako ^a   Hayashi, Mikio ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b Nagasaki Prefectural Shimabara Hospital   (Japan)

Author keywords

B cell activating factor belonging to the tumor necrosis factor family; Epididymo orchitis; IgG4 related disease; Prostatitis

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; BCG VACCINE; IMMUNOGLOBULIN G4; PREDNISOLONE; TUMOR NECROSIS FACTOR;

AGED; ARTICLE; B LYMPHOCYTE; BLADDER CANCER; BLOOD LEVEL; CASE REPORT; CYSTECTOMY; DISEASE ASSOCIATION; EPIDIDYMOORCHITIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOHISTOCHEMISTRY; INTRAVESICAL DRUG ADMINISTRATION; LYMPHOID CELL; MALE; PLASMA CELL; PRIORITY JOURNAL; PROSTATE; SWELLING; UROGENITAL TRACT DISEASE;

AGED; AUTOIMMUNE DISEASES; B-CELL ACTIVATION FACTOR RECEPTOR; HUMANS; IMMUNOGLOBULIN G; MALE; ORCHITIS; PROSTATE; TESTIS; URINARY BLADDER NEOPLASMS;

EID: 84905043250     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2013.852841     Document Type: Article

References (15)

1. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team: a novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22:1-14.
2. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539-51.
3. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21-30.
4. Bösmü ller H, von Weyhern CH, Adam P, Alibegovic V, Mikuz G, Fend F. Paratesticular fibrous pseudotumor-An IgG4-related disorder? Virchows Arch. 2011;458:109-13.
5. Stadanlick JE, Cancro MP. BAFF and the plasticity of peripheral B cell tolerance. Curr Opin Immunol. 2008;20:158-61.
6. Kalled SL. Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production. Semin Immunol. 2006;18:290-6.
7. Kiyama K, Kawabata D, Hosono Y, Kitagori K, Yukawa N, Yoshifuji H, et al. Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance. Arthritis Res Ther. 2012;14:R86.
8. Yamanishi H, Kumagi T, Yokota T, Azemoto N, Koizumi M, Kobayashi Y, et al. Clinical significance of B cell-Activating factor in autoimmune pancreatitis. Pancreas. 2011;40:840-5.
9. Watanabe T, Yamashita K, Fujikawa S, Sakurai T, Kudo M, Shiokawa M, et al. Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis. Arthritis Rheum. 2012;64:914-24.
10. Smyrk TC. Pathological features of IgG4-related sclerosing disease. Curr Opin Rheumatol. 2011;23:74-9.
11. Shimizu I, Nasu K, Sato K, Ueki H, Akahane D, Sumi M, et al. Lymphadenopathy of IgG4-related sclerosing disease: three case reports and review of literature. Int J Hematol. 2010;92:751-6.
12. Deshpande V, Gupta R, Sainani N, Sahani DV, Virk R, Ferrone C, et al. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am J Surg Pathol. 2011;35:26-35.
13. Masaki Y, Kurose N, Umehara H. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematop. 2011;51:13-20.
14. Okazaki K, Umehara H. Are classification criteria for IgG4-RD now possible? The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan. Int J Rheumatol. 2012;2012:357071.
15. Takuma K, Kamisawa T, Gopalakrishna R, Hara S, Tabata T, Inaba Y, et al. Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol. 2012;18:1015-20.